Forum Financial Management LP bought a new position in shares of Fresenius Medical Care AG (NYSE:FMS - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 10,891 shares of the company's stock, valued at approximately $247,000.
Several other large investors have also added to or reduced their stakes in the business. Venturi Wealth Management LLC grew its stake in Fresenius Medical Care by 8.4% during the fourth quarter. Venturi Wealth Management LLC now owns 5,700 shares of the company's stock worth $129,000 after purchasing an additional 441 shares during the period. PNC Financial Services Group Inc. grew its stake in Fresenius Medical Care by 5.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,278 shares of the company's stock valued at $210,000 after acquiring an additional 442 shares during the period. Smartleaf Asset Management LLC grew its stake in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock valued at $28,000 after acquiring an additional 806 shares during the period. DAVENPORT & Co LLC grew its stake in Fresenius Medical Care by 1.5% in the fourth quarter. DAVENPORT & Co LLC now owns 58,147 shares of the company's stock valued at $1,316,000 after acquiring an additional 862 shares during the period. Finally, Signaturefd LLC grew its stake in Fresenius Medical Care by 16.6% in the fourth quarter. Signaturefd LLC now owns 7,393 shares of the company's stock valued at $167,000 after acquiring an additional 1,052 shares during the period. Institutional investors and hedge funds own 8.37% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on FMS. Morgan Stanley reissued an "underweight" rating on shares of Fresenius Medical Care in a research note on Thursday, May 15th. Truist Financial raised their price objective on Fresenius Medical Care from $25.00 to $30.00 and gave the company a "hold" rating in a research note on Monday, May 12th. Finally, Wall Street Zen began coverage on Fresenius Medical Care in a research note on Tuesday, May 20th. They issued a "strong-buy" rating for the company. One research analyst has rated the stock with a sell rating, two have given a hold rating, one has issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $27.80.
Get Our Latest Analysis on FMS
Fresenius Medical Care Stock Up 1.5%
Shares of FMS stock traded up $0.42 during trading hours on Monday, reaching $28.82. The company had a trading volume of 462,398 shares, compared to its average volume of 332,477. Fresenius Medical Care AG has a 12 month low of $17.93 and a 12 month high of $30.46. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The business has a fifty day simple moving average of $26.05 and a 200-day simple moving average of $24.35. The company has a market cap of $16.91 billion, a price-to-earnings ratio of 23.82, a price-to-earnings-growth ratio of 0.76 and a beta of 0.85.
Fresenius Medical Care (NYSE:FMS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.01. Fresenius Medical Care had a return on equity of 6.04% and a net margin of 3.43%. The company had revenue of $5.54 billion for the quarter, compared to analyst estimates of $4.71 billion. On average, research analysts expect that Fresenius Medical Care AG will post 1.51 earnings per share for the current fiscal year.
Fresenius Medical Care Increases Dividend
The business also recently announced an annual dividend, which will be paid on Friday, June 6th. Stockholders of record on Friday, May 23rd will be issued a $0.7871 dividend. This represents a dividend yield of 1.9%. The ex-dividend date is Friday, May 23rd. This is a positive change from Fresenius Medical Care's previous annual dividend of $0.44. Fresenius Medical Care's dividend payout ratio (DPR) is currently 49.11%.
About Fresenius Medical Care
(
Free Report)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Recommended Stories
Before you consider Fresenius Medical Care AG & Co. KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care AG & Co. KGaA wasn't on the list.
While Fresenius Medical Care AG & Co. KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
